Microbiological fluorescence observatory for antibiotic resistance tracking
The accurate quantification of microbial populations is critical for understanding how microbes evolve and adapt to stressful environments. This, in turn, can help improve rationales for drug deployment aimed at minimising the evo...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
ChronosAntibiotics
Exploring the bacterial cell cycle to re sensitize antibioti...
3M€
Cerrado
HGTCODONUSE
The evolutionary significance of synonymous variations Can...
2M€
Cerrado
COMBACTE-NET
Combatting Bacterial Resistance in Europe
221M€
Cerrado
SAF2014-56568-R
DESARROLLO DE NUEVOS ANTIMICROBIANOS BASADOS EN EL ESTUDIO D...
Cerrado
DRIVE-AB
DRIVING RE-INVESTMENT IN R&D AND RESPONSIBLE ANTIBIOTIC USE
11M€
Cerrado
AGL2016-75536-P
EVALUACION DE LOS BACTERIOFAGOS EN LA TRANSFERENCIA DE GENES...
203K€
Cerrado
Información proyecto MuFLOART
Duración del proyecto: 19 meses
Fecha Inicio: 2018-08-08
Fecha Fin: 2020-03-31
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
The accurate quantification of microbial populations is critical for understanding how microbes evolve and adapt to stressful environments. This, in turn, can help improve rationales for drug deployment aimed at minimising the evolution of antibiotic resistance. Working on ERC-funded research into how microbial communities optimise their virulence traits and mediate drug-resistance, our team identified a need for a low cost photometry device capable of high-throughput quantification of microbial phenotypes such as microbial growth rates and metabolic efficiencies; microbial dose responses and susceptibility to antibiotics; antibiotic interactions datasets; microbial individuality and heterogeneity data and population mean gene expression profiles for fluorescently labeled genes. There are multiple positive consequences of having these capabilities at low cost: we can create high-throughput data pipelines for microbiology research, particularly for evolutionary studies or phenotypic screens; we can improve the dissemination of high-quality phenotypic data analysis algorithms (such as synergy tests for antibiotics) and so provide standardisation for those phenotypic assays; schools can benefit from the low-costs laboratory hardware and bring data analysis for microbiology into their mathematics, biology or computer science teaching; our lightweight devices with small footprints can be used to access geographically hard-to-reach areas where drug resistance phenotyping could be conducted using either battery or solar power. We are, therefore, now in the process of creating two prototypes that can perform these functions and we are seeking funding to finalise their design and field test the devices in three different settings: a partner research laboratory studying microbial evolution, a hospital research laboratory studying antimicrobial resistance and finally schools in a top-10 deprived area of the UK that cannot afford biotechnology equipment for teaching science.